Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Renal Allograft”

11 trials

Showing 11 of 11 results

Large-scale testing (Phase 3)Ended earlyNCT00137345
What this trial is testing

Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Wyeth is now a wholly owned subsidiary of Pfizer 500
Post-approval studies (Phase 4)Study completedNCT00374647
What this trial is testing

Study to Evaluate Safety and Efficacy of Early Calcineurin Inhibitor Withdrawal in Primary Renal Allografts

Who this might be right for
Primary Renal Allograft
University of Cincinnati 17
Testing effectiveness (Phase 2)Study completedNCT00365846
What this trial is testing

"A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52) Therapy in Primary Renal Allograft Transplantation"

Who this might be right for
Renal Transplant
University of Wisconsin, Madison 29
Post-approval studies (Phase 4)UnknownNCT00252655
What this trial is testing

Use of Sirolimus vs. Tacrolimus For African-American Renal Transplant Recipients

Who this might be right for
Kidney Transplantation
Wayne State University 40
Post-approval studies (Phase 4)Study completedNCT00121810
What this trial is testing

Kidney Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Hoffmann-La Roche 305
Large-scale testing (Phase 3)Study completedNCT01680861
What this trial is testing

Tacrolimus/Everolimus Versus Tacrolimus/Enteric-Coated Mycophenolate Sodium

Who this might be right for
Transplant; Failure, Kidney
Gaetano Ciancio 32
Post-approval studies (Phase 4)Looking for participantsNCT04989491
What this trial is testing

Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Received an EBV Seropositive Kidney Allograft

Who this might be right for
Epstein-Barr Virus Infections
University Hospital, Strasbourg, France 120
Testing effectiveness (Phase 2)Ended earlyNCT01856257
What this trial is testing

Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen

Who this might be right for
Primary Renal Allograft CandidateKidney Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 71
Not applicableEnded earlyNCT00957736
What this trial is testing

Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Cancer
Vanderbilt-Ingram Cancer Center 252
Not applicableStudy completedNCT04446546
What this trial is testing

Results of Cold Stored Allografts in Vascular Access

Who this might be right for
End Stage Renal Failure on DialysisHemodialysis Access Failure
Central Hospital, Nancy, France 120
Not applicableStudy completedNCT02700516
What this trial is testing

Recurrent Glomerulonephritis After Renal Transplantation

Who this might be right for
Glomerulonephritis
Istanbul University 360

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation